FDA issues boxed warning on osteoporosis drug Prolia
The following is from MedPage Today. The FDA added a boxed warning to the label of the osteoporosis drug denosumab (Prolia) over the risk of severe hypocalcemia in patients with advanced chronic kidney disease (CKD), the agency announced Friday. After a […]
The post FDA issues boxed warning on osteoporosis drug Prolia appeared first on Sharyl Attkisson.
Continue reading FDA issues boxed warning on osteoporosis drug Prolia on sharylattkisson.com.
